FDA Inspection 702550 — ENDO USA, Inc

ENDO USA, Inc — FEI 2410861

The FDA completed an inspection of ENDO USA, Inc on Dec 20, 2010 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 20, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rye, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.